Personal information

No personal information available

Activities

Collapse all

Employment (2)

Wistar Institute: Philadelphia, PA, US

2018-04-01 to present | Postdoc (Gene Expression)
Employment
Source: Self-asserted source
Jianhuang Lin

Karolinska Institutet: Stockholm, SE

2017-04-03 to 2018-03-31 (Microbiology, Tumor and Cell Biology (MTC))
Employment
Source: Self-asserted source
Jianhuang Lin

Education and qualifications (2)

University of Tsukuba: Tsukuba, Ibaraki, JP

2012-04-01 to 2017-03-01 | PhD (Molecular Infection Biology)
Education
Source: Self-asserted source
Jianhuang Lin

Fuzhou University: Fuzhou, Fujian, CN

2007-09-01 to 2011-07-01 | bachelor (Biological engineering)
Education
Source: Self-asserted source
Jianhuang Lin

Funding (1)

Targeting ER stress pathway in CARM1-expressing Ovarian Cancer

2020-03-01 to 2022-02-28 | Grant
Ovarian Cancer Research Alliance (New York, US)
URL: https://app.dimensions.ai/details/grant/grant.8658047
GRANT_NUMBER:

649658
Source: Self-asserted source
Jianhuang Lin via DimensionsWizard

Works (13)

Targeting the IRE1α/XBP1s pathway suppresses CARM1-expressing ovarian cancer

Nature Communications
2021-12 | Journal article
DOI: 10.1038/s41467-021-25684-3
Part of ISSN: 2041-1723
Source: Self-asserted source
Jianhuang Lin

The SETDB1-TRIM28 Complex Suppresses Antitumor Immunity.

Cancer immunology research
2021-12-01 | Journal article
DOI: 10.1158/2326-6066.cir-21-0754
PMID: 34848497
Source: Self-asserted source
Jianhuang Lin

m<sup>6</sup>A-independent genome-wide METTL3 and METTL14 redistribution drives the senescence-associated secretory phenotype.

Nature cell biology
2021-04-01 | Journal article
DOI: 10.1038/s41556-021-00656-3
PMID: 33795874
Source: Self-asserted source
Jianhuang Lin

Targeting glutamine dependence through GLS1 inhibition suppresses ARID1A-inactivated clear cell ovarian carcinoma

Nature Cancer
2021-02 | Journal article
DOI: 10.1038/s43018-020-00160-x
Part of ISSN: 2662-1347
Source: Self-asserted source
Jianhuang Lin

ARID2 deficiency correlates with the response to immune checkpoint blockade in melanoma

Journal of Investigative Dermatology
2020-12 | Journal article
DOI: 10.1016/j.jid.2020.11.026
Part of ISSN: 0022-202X
Source: Self-asserted source
Jianhuang Lin

Topoisomerase 1 cleavage complex enables pattern recognition and inflammation during senescence

Nature Communications
2020-12 | Journal article
DOI: 10.1038/s41467-020-14652-y
Part of ISSN: 2041-1723
Source: Self-asserted source
Jianhuang Lin

EZH2 Inhibition Sensitizes CARM1-High, Homologous Recombination Proficient Ovarian Cancers to PARP Inhibition

Cancer Cell
2020-01-30 | Journal article
DOI: 10.1016/j.ccell.2019.12.015
Part of ISSN: 1535-6108
Source: Self-asserted source
Jianhuang Lin

ROR1 regulates chemoresistance in Breast Cancer via modulation of drug efflux pump ABCB1

Scientific Reports
2020-01-19 | Journal article
DOI: 10.1038/s41598-020-58864-0
Part of ISSN: 2045-2322
Source: Self-asserted source
Jianhuang Lin

ARID1A promotes genomic stability through protecting telomere cohesion.

Nature communications
2019-09-06 | Journal article
DOI: 10.1038/s41467-019-12037-4
PMID: 31492885
Source: Self-asserted source
Jianhuang Lin
grade
Preferred source (of 3)‎

The cohesin loader NIPBL interacts with pre-ribosomal RNA and treacle to regulate ribosomal RNA synthesis

2019-06-03 | Journal article
DOI: 10.1101/658492
Source: Self-asserted source
Jianhuang Lin

Efficient DNA binding of NF-κB requires the chaperone-like function of NPM1.

2017-04 | Journal article
DOI: 10.1093/nar/gkw1285
PMID: 28003476
PMC: PMC5397172
Contributors: Lin J; Kato M; Nagata K; Okuwaki M
Source: Self-asserted source
Jianhuang Lin via Europe PubMed Central

Functional characterization and efficient detection of Nucleophosmin/NPM1 oligomers.

2016-11 | Journal article
DOI: 10.1016/j.bbrc.2016.10.125
PMID: 27983985
Contributors: Lin J; Hisaoka M; Nagata K; Okuwaki M
Source: Self-asserted source
Jianhuang Lin via Europe PubMed Central

Selective regulation of type II IFN-inducible genes by NPM1/nucleophosmin

Journal article
DOI: 10.1002/1873-3468.12952
PMID: 29251779
Source: Self-asserted source
Jianhuang Lin

Peer review (2 reviews for 1 publication/grant)

Review activity for BMC cancer (2)
How many people are using ORCID?